Cystic fibrosis and a bill to fast track trials could present problems – June 26, 2009
Written by Alex on June 26, 2009 – 10:05 am
Legislation making it easier for people with rare diseases to enroll in clinical trials – chiefly by removing restrictions to government health benefits such as SSI if they do so – is making its way through Congress. The bill, called the “Improve Access to Clinical Trials Act” is co-sponsored by Representatives Edward J. Markey (D-MA) and Cliff Stearns (R-FL) and 30 members of the House of Representatives. The bill is specifically aimed at boosting enrollment in trials testing new treatments for cystic fibrosis, a condition that affects 30,000 people in the U.S. The long term effects of actual legislation to increase enrollment in trials are unknown. It might be, and I have a feeling it will be, the start of slippery slope that makes enrollment of ever more subjects in trials an easier and less regulated process. Fast tracking trials is risky. Having the government endorse such practices could prove disastrous. I hope I’m wrong and we’ll keep an eye on how this proceeds in the coming weeks and months…
Children’s in cystic fibrosis trial test – Bizjournals.com – Charlotte, NC, USA – Vertex will conduct three different clinical trials as part of the registration program for the drug involving approximately 110 sites … See all stories on this topic